Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

Market Cap	5.39B +10.0%
Revenue (ttm)	2.74B -18.9%
Net Income	44.19M -77.5%
EPS	0.12 -76.9%
Shares Out	379.33M
PE Ratio	118.33
Forward PE	n/a
Dividend	0.30 (2.17%)
Ex-Dividend Date	n/a

Volume	6,940,002
Average Volume	7,302,956
Open	14.62
Previous Close	13.85
Day's Range	13.57 - 14.62
52-Week Range	13.45 - 23.22
Beta	0.49
RSI	41.09
Earnings Date	Mar 27, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

• Industry: Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 3,657
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300233

Financial Performance

In 2025, SHE:300233's revenue was 2.74 billion, a decrease of -18.87% compared to the previous year's 3.37 billion. Earnings were 44.19 million, a decrease of -77.55%.